Drugs that modify disease activity include traditional DMARDs (particularly methotrexate), biologic agents such as tumor necrosis factor (TNF) - alpha antagonists or other non-TNF biologic agents, and other drugs that are immunomodulatory, cytotoxic, or immunosuppressive.